【medical-news】【资讯翻译】1型糖尿病通过炎症蛋白calprotectin增加心脏病风险
这个帖子发布于 12 年零 53 天前，其中的信息可能已发生改变或有所发展。
★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★
★★
先认领，认领成功者，再提交译文。 ★★
★★
认领翻译的战友请跟帖注明”认领本文翻译，若48小时内未完成，请其他战友认领！“ ★★
★★ 只许一人认领，后来者的认领无效。 ★★
★★ 认领前后请刷新页面，看是否已被认领或自己是否认领成功。 ★★
★★ 认领成功后请及时提交译文，逾时不交其他人可继续认领。 ★★
★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★
新近参与本次活动的会员请查看：【公告】动态版重启资讯翻译计划：我为人人，人人为我，共同提高 翻译时请把不确定的地方用红色字体标注，
寻找最近的翻译贴请查看：点击进入
翻译时请参照版规 【版务】科技动态版版规及加分细则（ 2014-02-21 更新）
翻译三天未加分找 【版务】加分申诉点击
举报和合并加分专贴 【公告】版务管理之【举报和合并加分专贴】仅限于10分以下战友
希望参与动态版其他活动的会员请查看版面右边栏的置顶部分。
原文链接 http://www.medicalnewstoday.com/releases/260240.php
Inflammatory Protein Links Type 1 Diabetes And Heart Disease
Article Date: 09 May 2013 - 1:00 PDT
Type 1 (insulin-dependent) diabetesappears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque. The findings, made in mice and confirmed with human data, suggest new therapeutic targets for reducing heart disease in people with type 1 diabetes. Led by Columbia University Medical Center (CUMC) researchers in collaboration with investigators at New York University and the University of Pittsburgh, the study was published in the online edition of Cell Metabolism.
Diabetes is known to raise the risk foratherosclerosis, a disease in which fatty deposits known as plaque accumulate inside arteries. Over time, the arteries harden and narrow, leading to coronary artery disease and other forms of heart disease. Atherosclerosis is the leading cause of heart attacks, strokes, and peripheral vascular disease - collectively known as coronary heart disease, the leading cause of death in the United States.
Scientists have known that diabetes leads to atherosclerosis. The study shows that this is associated with increased circulating levels of inflammatory white blood cells (WBCs), which contribute to the build-up of plaque. "But exactly how diabetes causes white blood cells to proliferate and lead to heart disease has been a mystery," said study co-leader Ira J. Goldberg, MD, Dickinson W. Richards Professor of Medicine at CUMC.
In studies of mice with type 1 diabetes, Dr. Goldberg and his colleagues found that high blood sugar stimulates a type of inflammatory WBC known as neutrophils to release the protein calprotectin (also known as S100A8/9). The calprotectin travels to the bone marrow, where it binds to a cell-surface receptor called RAGE receptor, on common myeloid progenitor cells, which are involved in the production of various types of blood cells. This, in turn, leads to the proliferation of cells, known as granulocyte macrophage progenitor cells, which trigger the proliferation of even more neutrophils and of monocytes (another type of inflammatory WBC). Finally, these new WBCs enter the circulation and make their way to arterial plaques, fueling their progression.
The researchers also found that normalizing the mice's blood glucose dampened this pathway, leading to an overall decrease in inflammation.
To determine the relevance of these findings in humans, the researchers analyzed data from 290 patients in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study, led by EDC Principal Investigator Trevor J. Orchard, who has been following people with diabetes for 18 years. Total WBC, neutrophil, and monocyte counts were all significantly associated with the development of coronary artery disease. The researchers also analyzed blood samples from a subgroup of EDC patients. Those who had developed coronary artery disease had significantly higher levels of calprotectin, compared with patients who had not developed coronary artery disease.
"The human data appear to fit with the animal data, in that both WBCs and calprotectin are associated with heart disease," said co-lead author Andrew J. Murphy, PhD, postdoctoral fellow in medicine at CUMC. The other lead author is Prabhakara R. Nagareddy, PhD, postdoctoral fellow at CUMC.
"Our findings point to the importance of controlling blood levels to limit the production of inflammatory cells that drive atherosclerosis; they also suggest novel therapeutic strategies, such as inhibiting the production of calprotectin or preventing its binding to the RAGE receptor," said study co-leader Alan R. Tall, MD, the Tilden Weger Bieler Professor of Medicine at CUMC.
The CUMC team is currently studying how type 2 diabetes increases one's risk for heart disease.
★★
先认领，认领成功者，再提交译文。 ★★
★★
认领翻译的战友请跟帖注明”认领本文翻译，若48小时内未完成，请其他战友认领！“ ★★
★★ 只许一人认领，后来者的认领无效。 ★★
★★ 认领前后请刷新页面，看是否已被认领或自己是否认领成功。 ★★
★★ 认领成功后请及时提交译文，逾时不交其他人可继续认领。 ★★
★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★★
新近参与本次活动的会员请查看：【公告】动态版重启资讯翻译计划：我为人人，人人为我，共同提高 翻译时请把不确定的地方用红色字体标注，
寻找最近的翻译贴请查看：点击进入
翻译时请参照版规 【版务】科技动态版版规及加分细则（ 2014-02-21 更新）
翻译三天未加分找 【版务】加分申诉点击
举报和合并加分专贴 【公告】版务管理之【举报和合并加分专贴】仅限于10分以下战友
希望参与动态版其他活动的会员请查看版面右边栏的置顶部分。
原文链接 http://www.medicalnewstoday.com/releases/260240.php
Inflammatory Protein Links Type 1 Diabetes And Heart Disease
Article Date: 09 May 2013 - 1:00 PDT
Type 1 (insulin-dependent) diabetesappears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque. The findings, made in mice and confirmed with human data, suggest new therapeutic targets for reducing heart disease in people with type 1 diabetes. Led by Columbia University Medical Center (CUMC) researchers in collaboration with investigators at New York University and the University of Pittsburgh, the study was published in the online edition of Cell Metabolism.
Diabetes is known to raise the risk foratherosclerosis, a disease in which fatty deposits known as plaque accumulate inside arteries. Over time, the arteries harden and narrow, leading to coronary artery disease and other forms of heart disease. Atherosclerosis is the leading cause of heart attacks, strokes, and peripheral vascular disease - collectively known as coronary heart disease, the leading cause of death in the United States.
Scientists have known that diabetes leads to atherosclerosis. The study shows that this is associated with increased circulating levels of inflammatory white blood cells (WBCs), which contribute to the build-up of plaque. "But exactly how diabetes causes white blood cells to proliferate and lead to heart disease has been a mystery," said study co-leader Ira J. Goldberg, MD, Dickinson W. Richards Professor of Medicine at CUMC.
In studies of mice with type 1 diabetes, Dr. Goldberg and his colleagues found that high blood sugar stimulates a type of inflammatory WBC known as neutrophils to release the protein calprotectin (also known as S100A8/9). The calprotectin travels to the bone marrow, where it binds to a cell-surface receptor called RAGE receptor, on common myeloid progenitor cells, which are involved in the production of various types of blood cells. This, in turn, leads to the proliferation of cells, known as granulocyte macrophage progenitor cells, which trigger the proliferation of even more neutrophils and of monocytes (another type of inflammatory WBC). Finally, these new WBCs enter the circulation and make their way to arterial plaques, fueling their progression.
The researchers also found that normalizing the mice's blood glucose dampened this pathway, leading to an overall decrease in inflammation.
To determine the relevance of these findings in humans, the researchers analyzed data from 290 patients in the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study, led by EDC Principal Investigator Trevor J. Orchard, who has been following people with diabetes for 18 years. Total WBC, neutrophil, and monocyte counts were all significantly associated with the development of coronary artery disease. The researchers also analyzed blood samples from a subgroup of EDC patients. Those who had developed coronary artery disease had significantly higher levels of calprotectin, compared with patients who had not developed coronary artery disease.
"The human data appear to fit with the animal data, in that both WBCs and calprotectin are associated with heart disease," said co-lead author Andrew J. Murphy, PhD, postdoctoral fellow in medicine at CUMC. The other lead author is Prabhakara R. Nagareddy, PhD, postdoctoral fellow at CUMC.
"Our findings point to the importance of controlling blood levels to limit the production of inflammatory cells that drive atherosclerosis; they also suggest novel therapeutic strategies, such as inhibiting the production of calprotectin or preventing its binding to the RAGE receptor," said study co-leader Alan R. Tall, MD, the Tilden Weger Bieler Professor of Medicine at CUMC.
The CUMC team is currently studying how type 2 diabetes increases one's risk for heart disease.
